News | 18 May 2012
A hit product propelled this maker of generic drugs from a money-losing operation to the top of the Globe 100 list. By Robert Weisman Craig A. Wheeler, chief executive of Momenta Pharmaceuticals Inc. Momenta Pharmaceuticals Inc. has discovered that ...
Click on the link to read the full article at Boston Globe
(This link will open in a new window)